RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,153 | -77.5% | 21,064 | -68.7% | 0.00% | – |
| Q2 2023 | $80,640 | -72.8% | 67,200 | +98.4% | 0.00% | – |
| Q1 2023 | $296,068 | +11.1% | 33,875 | +1.7% | 0.00% | – |
| Q4 2022 | $266,584 | -18.7% | 33,323 | -50.4% | 0.00% | – |
| Q3 2022 | $328,000 | +475.4% | 67,250 | +549.0% | 0.00% | – |
| Q2 2022 | $57,000 | – | 10,362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |